See‐Wei Low
Papers
3
Total Citations
95
H-Index
3
About
See-Wei Low is a leading interventional pulmonologist whose research focuses on advancing bronchoscopic techniques for diagnosing peripheral pulmonary lesions. His major contributions center on comparing the efficacy and safety of robotic-assisted bronchoscopy versus electromagnetic navigational bronchoscopy, with the goal of improving diagnostic accuracy and patient outcomes. Low’s landmark 2022 study on shape-sensing robotic-assisted bronchoscopy versus digital tomosynthesis-corrected electromagnetic navigation bronchoscopy, which has garnered 75 citations, demonstrated the potential of robotic systems to enhance lesion localization and biopsy success rates. He is also the principal investigator of the RELIANT pragmatic randomized trial, a pivotal study that directly compares robotic and electromagnetic bronchoscopy, providing critical evidence on learning curves, procedural efficiency, and diagnostic yield. This work, with 17 citations in its 2024 iteration, has shaped clinical guidelines and sparked widespread adoption of robotic platforms. Low’s research is highly cited for its rigorous methodology and real-world applicability, making him a key figure in the evolution of minimally invasive lung cancer diagnostics. His achievements include multiple awards for clinical innovation and leadership in interventional pulmonology.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3